Completed PHASE1 INTERVENTIONAL 1-arm NCT03473184

A 4-Day Study to Evaluate the Photoxicity of Diacerein 1% Topical Ointment in Healthy Volunteers

A 4 Day, Randomized Study to Evaluate the Potential of CCP-020 (Diacerein 1%) Topical Ointment to Induce a Phototoxicity Skin Reaction in Healthy Subjects, Using a Controlled Photopatch Test

Sponsor: Castle Creek Pharmaceuticals, LLC

Conditions Healthy

Interventions Diacerein 1% ointment

Updated 10 times since 2018 Last updated: Feb 5, 2020 Started: Dec 12, 2017 Primary completion: Dec 15, 2017 Completion: Dec 15, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy and is currently completed. Castle Creek Pharmaceuticals, LLC leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1
Dec 2021 — Dec 2022 [monthly]

Completed PHASE1

▶ Show 5 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE1
Mar 2020 — Jan 2021 [monthly]

Completed PHASE1
Mar 2019 — Mar 2020 [monthly]

Completed PHASE1
Jun 2018 — Mar 2019 [monthly]

Completed PHASE1
Apr 2018 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Castle Creek Pharmaceuticals, LLC

Data source: Castle Creek Pharmaceuticals, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fair Lawn, United States